Features of partial remission in children with type 1 diabetes using the insulin dose-adjusted A1c definition and risk factors associated with nonremission
Tsz Wai Catherine Wong, Man Yee Shirley Wong, Wai Man Betty But
Ann Pediatr Endocrinol Metab. 2021;26(2):118-125.   Published online 2021 Jun 30     DOI: https://doi.org/10.6065/apem.2040202.101
Citations to this article as recorded by Crossref logo
Immunometabolic biomarkers for partial remission in type 1 diabetes mellitus
Laia Gomez-Muñoz, Juan Dominguez-Bendala, Ricardo L. Pastori, Marta Vives-Pi
Trends in Endocrinology & Metabolism.2024; 35(2): 151.     CrossRef
Clinical Outcomes in Pediatric Patients With Type 1 Diabetes With Early Versus Late Diagnosis: Analysis From the DPV Registry
Johanna Hammersen, Sascha R. Tittel, Clemens Kamrath, Katharina Warncke, Angela Galler, Ulrike Menzel, Melanie Hess, Thomas Meißner, Beate Karges, Reinhard W. Holl
Diabetes Care.2024; 47(10): 1808.     CrossRef
What Is a Honeymoon in Type 1, Can It Go into Remission?
Anuradha Viswanathan, Jamie R. Wood, Betul A. Hatipoglu
Endocrinology and Metabolism Clinics of North America.2023; 52(1): 175.     CrossRef
Influence of the occurrence and duration of partial remission on short-term metabolic control in type 1 diabetes: the DIABHONEY pediatric study
Laure Boutsen, Elise Costenoble, Olivier Pollé, Kezban Erdem, Céline Bugli, Philippe A. Lysy
Therapeutic Advances in Endocrinology and Metabolism.2023;[Epub]     CrossRef
Complete remission in children and adolescents with type 1 diabetes mellitus—prevalence and factors
Kristina Podolakova, Lubomir Barak, Emilia Jancova, Simona Tarnokova, Ludmila Podracka, Zuzana Dobiasova, Martina Skopkova, Daniela Gasperikova, Juraj Stanik
Scientific Reports.2023;[Epub]     CrossRef
Association between sitagliptin plus vitamin D3 (VIDPP-4i) use and clinical remission in patients with new-onset type 1 diabetes: a retrospective case-control study
Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, Marcelo Müller de Arruda, Geane Moron Beato, Graciele Alves Corrêa Lima Verde, Georgiana Bianchini, Pedro Rosário Moraes Casalenuovo, Aline Aparecida Agostini Argolo, Lucilene Telles de Souza, Flávia Gome
Archives of Endocrinology and Metabolism.2023;[Epub]     CrossRef
Early weight gain after diagnosis may have an impact on remission status in children with new‐onset type 1 diabetes mellitus
Dicle Canoruc Emet, Hande Nur Karavar, Onur Gozmen, Arife Aslan Agyar, Yağmur Ünsal, Merve Canturk, Pınar Cengiz, Dogus Vuralli, Z. Alev Ozon, E. Nazlı Gonc
Journal of Diabetes.2023; 15(12): 1011.     CrossRef
Determinants and Characteristics of Insulin Dose Requirements in Children and Adolescents with New-Onset Type 1 Diabetes: Insights from the INSENODIAB Study
Maude Beckers, Olivier Polle, Paola Gallo, Noémie Bernard, Céline Bugli, Philippe A. Lysy, Bright Starling Emerald
Journal of Diabetes Research.2023; 2023: 1.     CrossRef
Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes
Laia Gomez-Muñoz, David Perna-Barrull, Josep M. Caroz-Armayones, Marta Murillo, Silvia Rodriguez-Fernandez, Aina Valls, Federico Vazquez, Jacobo Perez, Raquel Corripio, Luis Castaño, Joan Bel, Marta Vives-Pi
Frontiers in Immunology.2022;[Epub]     CrossRef
Postinitial remission in children with type 1 diabetes mellitus
Kristína Podoláková, Denisa Lobotková, Emília Jančová, Ľudmila Podracká, Ľubomír Barák, Juraj Staník
Česko-slovenská pediatrie.2022; 77(2): 72.     CrossRef
Postinitial remission in children with type 1 diabetes mellitus
Kristína Podoláková, Denisa Lobotková, Emília Jančová, Ľudmila Podracká, Ľubomír Barák, Juraj Staník
Česko-slovenská pediatrie.2022; 77(2): 72.     CrossRef